Public Reporting of Ventilator-associated Pneumonia (VAP)
York Central Hospital will post ventilator-associated pneumonia (VAP) information on our website as of April 30th, 2009. Like all Ontario hospitals with ICUs, we will report our quarterly rate and case count VAP acquired at our facility for each three-month period, beginning with January, February and March 2009. The information is also available on the Ministry of Health and Long-Term Care’s website: www.ontario.ca/patientsafety.
What is ventilator-associated pneumonia?
For our public reporting purposes, ventilator-associated pneumonia (VAP) is defined as a pneumonia (lung infection) occurring in patients in an intensive care unit (ICU), requiring external mechanical breathing support (a ventilator) through a breathing tube for more than 48 hours.
What happens when you get VAP?
Patients with VAP show symptoms of either a fever or lower body temperature. The mucous or phlegm that is brought up from their lungs is infected.
How is VAP treated?
Since VAP is caused by a bacterial infection in the lungs, it is treated using antibiotics. Sometimes it can be difficult to tell if a patient has developed a VAP, as they are already critically ill, and may have a pre-existing infection. Professional care teams in ICUs do their best to use leading practices to prevent a VAP from occurring. Now that York Central Hospital is publicly reporting our VAP cases, we have an additional opportunity to measure and track our quality and patient safety improvements.
Why does VAP develop in ICU patients?
VAP can develop in patients for many reasons. Because patients are relying on an external machine (ventilator) to breath, their normal coughing, yawning, and deep breath reflexes are suppressed. Patients may also have a depressed immune system, making them more vulnerable to infection. ICU teams have many ways to try to assist patients with these normal breathing reflexes, but despite this, patients are still at risk for developing pneumonia.
Return to Top
|